We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.57 | 1.95% | 29.83 | 29.78 | 29.86 | 30.08 | 29.715 | 30.04 | 4,829,456 | 21:22:28 |
By Kim Richters
The U.K. Competition and Markets Authority is reviewing Roche Holding AG's (RO.EB) planned acquisition of Spark Therapeutics Inc. (ONCE), the regulator said Wednesday.
Swiss pharmaceuticals company Roche announced plans to acquire U.S.-based biotechnology company Sparks in February this year.
The authority is considering whether a merger would lead to a substantial lessening of competition within the United Kingdom and it seeks comments on the deal by Oct. 11, it said.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
September 25, 2019 02:39 ET (06:39 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions